A Q3 2025 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+10.1% YoY

Gross Profit

$914M52.6% margin

Operating Income

$360M20.7% margin

Net Income

$336M19.3% margin

EPS (Diluted)

$1.18

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

$362M

Free Cash Flow

$259M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$12.2B

Total Liabilities

$5.9B

Stockholders' Equity

$6.4B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.6B	+10.1%
Gross Profit	$914M	$855M	+6.9%
Operating Income	$360M	$333M	+8.1%
Net Income	$336M	$282M	+19.1%

Revenue Segments

Agilent CrossLab

$744M43%

Life Sciences and Applied Markets

$670M39%

Applied Markets

$324M19%

Geographic Segments

Americas

$683M39%

Asia Pacific

$563M32%

Europe

$492M28%